Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis
Clinical trial NCT02308670 · COMPLETED
Trial details
- NCT number
- NCT02308670
- Sponsor
- University at Buffalo
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-10-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.